Researchers with the UMN Genomics Center’s Innovation Lab and the College of Science and Engineering are working to commercialize a new robot that improves the intricate microinjection process currently used for cloning, in vitro fertilization, cell labeling, cryopreservation and more.
University of Minnesota Stem Cell Institute faculty members Walter Low, PhD (Neurosurgery) and Susan Keirstead, PhD (Integrative Biology and Physiology), together with Jian-Ping Wang, PhD (Electrical and Computer Engineering), and Theoden Netoff, PhD (Biomedical Engineering), are among a team of researchers
The University of Minnesota Genomics Center has launched a new CoLab offering researchers access to space and instruments, plus specialized training in genomic methods. Center leaders hope the CoLab, available to U of M researchers at no cost, helps free researchers to experiment more with designs and accelerates project turnarounds.
Never ones to shy away from a challenge, David Potter, MD, PhD, and his team at the Masonic Cancer Center are developing new therapies to target extra-tough breast cancer tumors. Using a class of diabetes drugs, researchers are working toward treatments to activate a patient’s immune system to fight particularly stubborn tumors. The team hopes to begin human clinical trials soon.
University of Minnesota Law Professor Francis X. Shen, JD, PhD, has co-authored the first introduction to brain science specifically for lawyers, judges, and those interested in the legal implications of neuroscience. Brain Science for Lawyers, Judges, and Policymakers guides readers through the fundamentals of brain science and highlights the ever-increasing role neuroscience data plays in court cases and public policy.
The Consortium on Law and Values in Health, Environment & the Life Sciences hosted a May 1 virtual Lecture Series titled “When Law, Ethics & Medicine Collide.” It was the first webinar in the series, “Considering Medical Aid in Dying,” and featured three international experts on the law, ethics, and clinical realities of medical aid in dying, both in the U.S.
A new online tool, launched by the Masonic Institute for the Developing Brain (MIDB), allows researchers to better evaluate brain organization by identifying an individual’s neural networks. The tool aims to help clinicians develop personalized approaches for care.
The National Cancer Institute (NCI) at NIH renewed its designation of the Masonic Cancer Center (MCC) as a comprehensive cancer center last summer. MCC’s community engagement efforts and innovations to high-impact clinical trials were contributing factors in the renewal.
Thanks in part to initial seed money from UMN’s Clinical & Translational Science Institute’s Office of Discovery and Translation (ODAT), a new low-cost, portable magnetic resonance imaging (MRI) scanner may soon be commercially available.
Family members tracking the progress of hospitalized loved ones have a new tool to connect with clinicians.